| Open Price | 506.70 | Shares Traded | 35814 |
| High Price | 507.25 | 52 Wk High | 570.00 |
| Low Price | 501.70 | 52 Wk Low | 366.50 |
| Previous Close | 501.10 | Face Value | 5.00 |
| 52 Wk High Date | - | 52 Wk Low Date | - |
| Open Price | 505.05 | Shares Traded | 1007620 |
| High Price | 528.50 | 52 Wk High | 570.00 |
| Low Price | 501.10 | 52 Wk Low | 365.50 |
| Previous Close | 501.05 | Face Value | 5.00 |
| 52 Wk High Date | - | 52 Wk Low Date | - |
| Key Financials | Latest Qrtr. | Trailing Yr. | Full Yr. |
| Year End | Mar, 2012 | Mar, 2012 | Dec, 2011 |
| Sales (Rs.cr) | 1810.23 | 8345.49 | 7590.18 |
| Net Profit (Rs.cr) | 482.51 | 1237.94 | 700.54 |
| Net Profit Var (%) | - | 256.00 | -30.00 |
| EPS (Rs) | - | 16.60 | |
| P/E Ratio | - | 16.81 | 29.70 |
| Operating Profit Margin | - | 19.16 | - |
| CPS (Rs.) | - | - | 23.10 |
| P/C Ratio | - | - | 21.30 |
| Div% | - | - | - |
| Related Companies | ||
| Stock Name | Price | |
| CIPLA | 310.00 | |
| JBCHEPHARM | 62.70 | |
| JAYANTVITAMINS | 3.00 | |
| MERIND | 200.00 | |
| PIRHEALTH | 424.00 | |
| UNICHEMLAB | 132.00 | |
| ALEMBICLTD | 15.20 | |
| LYKALABS | 9.70 | |
| TTKHEALTH | 358.15 | |
| DRREDDY | 1,664.05 | |
| Fundamentals | |
| Market Capital (Rs.cr) | 20804.20 |
| EPS (Rs.)(TTM) | |
| P/E Ratio(TTM) | 16.81 |
| Book Value (Rs.) | 45.60 |
| Price to Book Value | 10.81 |
| Equity (Rs.cr.) | 211.06 |
| Traded Value (Rs.lac) | 410.77 |
| Announcements | |
| 19-04-2012 | Daiichi Sankyo and Ranbaxy to expand hybrid business model in Romania |
| 21-12-2011 | Ranbaxy announces consent decree with U.S. Food and Drug Administration |
| 06-03-2012 | Ranbaxy becomes the first company to launch generic Atorvastatin in Italy, Netherlands & Sweden |
| 12-07-2011 | Ranbaxy enters into a licensing agreement with Gilead Sciences |
| 12-01-2011 | Ranbaxy Laboratories allots equity shares |
| 09-05-2012 | Ranbaxy Laboratories appoints additional director |
| 25-08-2011 | Ranbaxy Laboratories appoints president & CFO |
| 23-01-2012 | Ranbaxy Laboratories gets UK MHRA nod for generic Singulair tablets |
| 22-02-2011 | Ranbaxy Laboratories recommends dividend |
| 31-01-2012 | Ranbaxy Laboratories to announce financial results |
| 10-10-2011 | Ranbaxy Laboratories to announce Q3 results |
| 15-02-2011 | Ranbaxy Laboratories to consider dividend |
| 07-12-2011 | Ranbaxy launches authorized generic version of caduet in the US |
| 26-07-2011 | Ranbaxy launches Letrozole tablets in UK, Romania & France |
| 31-03-2012 | Ranbaxy receives approval to Market RAN - ROSUVASTATIN in Canada |
| 05-09-2011 | Ranbaxy UK launches esomeprazole |
| Gross Deliverables | |||||
| Date | Del. Shares | Trd. Qty. | Del.(%) | Del. Value | Turnover |
| 15-05-2012 | 16382 | 90701 | 18.06 | 8073869 | 44,589.80 |
| 11-05-2012 | 31089 | 192288 | 16.17 | 14897849 | 92,659.60 |
| 09-05-2012 | 41485 | 746547 | 5.56 | 21258988 | 379,994.00 |
| 08-05-2012 | 10965 | 45068 | 24.33 | 5413420 | 22,614.50 |
| 04-05-2012 | 18019 | 82917 | 21.73 | 9005896 | 41,574.40 |
